Pernix Therapeutics Holdings – Files Chapter 11, Highbridge Capital to Serve as Stalking Horse in Asset Sale with $75.6mn (Mostly Credit) Opening Bid

February 18, 2019 – Pernix Therapeutics Holdings and 12 affiliated Debtors (NASDAQ: PTX, “Pernix” or the “Company”) filed for Chapter 11 protection with the U.S. Bankruptcy Court in the District of Delaware, lead case number 19-10329 [Docket No. 1]. The Company, a holding company that owns several subsidiaries, including specialty pharmaceutical companies, is represented by…